medical services, namely, diagnosing diseases featuring the following services - developing chemical markers which indicate the presence of disease states; determining biological targets for drugs, in order that the drugs may alleviate disease states and conditions in humans and animals; determining protein and peptide sequences for the purposes of identifying protein or peptide drug targets, and for developing sequencing databases; developing methodologies relating to the foregoing services, namely developing bioanalytical methods to increase the throughput of the identification and characterization of biological substances such as proteins used as biomarkers for a diagnosis or as drug targets, and developing biochemistry process and instrumentation for said foregoing services, and developing simplified methods of performing said foregoing services; and developing methods to reduce the sample sizes needed, and to increase the reliability of assays